A Tick Mannose-Binding Lectin Inhibitor Interferes with the Vertebrate Complement Cascade to Enhance Transmission of the Lyme Disease Agent  by Schuijt, Tim J. et al.
Cell Host & Microbe
ArticleA Tick Mannose-Binding Lectin Inhibitor
Interferes with the Vertebrate Complement Cascade
to Enhance Transmission of the Lyme Disease Agent
Tim J. Schuijt,1,2,5,* Jeroen Coumou,1,2 Sukanya Narasimhan,1 Jianfeng Dai,1 Kathleen DePonte,1 Diana Wouters,6
Mieke Brouwer,6 Anneke Oei,3 Joris J.T.H. Roelofs,4 Alje P. van Dam,7 Tom van der Poll,2 Cornelis van’t Veer,2
Joppe W. Hovius,2,9 and Erol Fikrig1,8,9
1Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06420, USA
2Center for Experimental and Molecular Medicine
3Department of Medical Microbiology
4Department of Pathology
Academic Medical Center, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands
5Department of Medical Microbiology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands
6Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center,
Amsterdam 1066 CX, The Netherlands
7Department of Medical Microbiology, Onze Lieve Vrouwe Gasthuis, Amsterdam 1091 AC, The Netherlands
8Howard Hughes Medical Institute, Chevy Chase, MD 20815-6789, USA
9These authors contributed equally to this work
*Correspondence: t.j.schuijt@amc.uva.nl
DOI 10.1016/j.chom.2011.06.010SUMMARY
The Lyme disease agent Borrelia burgdorferi is
primarily transmitted to vertebrates by Ixodes ticks.
The classical and alternative complement pathways
are important inBorreliaeradicationby the vertebrate
host. We recently identified a tick salivary protein,
designated P8, which reduced complement-medi-
ated killing of Borrelia. We now discover that P8 in-
terferes with the human lectin complement cascade,
resulting in impaired neutrophil phagocytosis and
chemotaxis and diminished Borrelia lysis. Therefore,
P8 was renamed the tick salivary lectin pathway
inhibitor (TSLPI). TSLPI-silenced ticks, or ticks ex-
posed to TSLPI-immune mice, were hampered in
Borrelia transmission. Moreover,Borrelia acquisition
and persistence in tick midguts was impaired in
ticks feeding on TSLPI-immunized, B. burgdorferi-
infected mice. Together, our findings suggest an
essential role for the lectin complement cascade in
Borrelia eradication and demonstrate how a vector-
borne pathogen co-opts a vector protein to facilitate
early mammalian infection and vector colonization.
INTRODUCTION
During the blood meal, Ixodes ticks can transmit various
pathogens to the vertebrate host, such as Borrelia burgdorferi
sensu lato, Anaplasma phagocytophilum, Babesia species, and
selected flaviviruses, among other agents (Estrada-Pen˜a and
Jongejan, 1999). Ticks introduce salivary proteins at the tick
bite site to suppress host defense mechanisms in order to136 Cell Host & Microbe 10, 136–146, August 18, 2011 ª2011 Elsevisuccessfully obtain a blood meal. Several anticoagulant, anti-
inflammatory, anticomplement, and immunosuppressive tick
salivary proteins have been identified (Hovius et al., 2008), which
could not only facilitate tick feeding but also enhance Borrelia
transmission to the mammalian host and Borrelia acquisition
by the tick vector (Schuijt et al., 2011a).
The complement cascade is a major part of the mammalian
innate immune response consisting of the classical, the alterna-
tive, and the lectin pathway and serves as a functional bridge
between innate and adaptive immune responses (Ricklin et al.,
2010). The most prominent role of the complement system is
to recognize and clear invading pathogens. Activation of the
complement cascade results in opsonization of the invading
microorganism, leading to enhanced phagocytosis, leukocyte
chemotaxis, and direct killing of pathogens by formation of the
membrane attack complex (MAC). Initiation of the classical
pathway relies on C1q binding to pathogens, either directly or
to antibody-opsonized pathogens. The lectin pathway is acti-
vated upon binding of mannose-binding lectin (MBL) or ficolins
(FCNs) to highly glycosylated pathogen-associated molecular
patterns (PAMPs) on the surface of pathogens (Ip et al., 2009;
Matsushita, 2009). Both MBL and FCNs form a complex with
proenzymes of MBL-associated serine proteases (MASPs) in
serum, which are activated upon binding of MBL and FCNs to
pathogens. Activated MASP-2 activates the complement cas-
cade by cleaving C4 and C2 to generate the C4b2a complex.
The alternative pathway spontaneously and continuously con-
verts C3, and its predominant role is amplification of comple-
ment activation initially triggered by the classical and/or lectin
pathway (Kishore and Reid, 2000).
Several tick salivary proteins from different tick species inhibit
the host complement system. A well-characterized tick comple-
ment inhibitor is the C5 activation inhibitor from the soft tick
Ornithodoros moubata OMCI that inhibits C5 activation by
binding C5 and preventing its activation by C5 convertaseer Inc.
Figure 1. Characterization, Protein Se-
quence, and Expression of TSLPI
(A) Multiple sequence alignment of I. scapularis
TSLPI aligned with two homologs of TSLPI in
I. ricinus. Amino acids in white on a black back-
ground are identical; residues in white on a gray
background are similar. Region inside the gray
box shows the predicted signal peptide sequence.
(B) Coomassie staining of rTSLPI on SDS-PAGE
before and after deglycosylation with PNGase F.
(C) I. scapularis saliva probed with rTSLPI-rabbit
antiserum or OVA-rabbit antiserum.
(D) Expression profile of TSLPI in salivary glands
(SG) of pathogen-free (clean) nymphs and
Borrelia-infected (Bb) nymphs. TSLPI expression
in unfed nymphs, after 24 and 72 hr of feeding, and
repleted nymphs. Results represent mean ± SEM
of values.
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hemolytic activity and the development of pathological features
in a rodent model for myasthenia gravis (Hepburn et al., 2007).
Other tick complement inhibitors, including Isac, Irac-1 and -2,
and Salp20, belong to the Isac protein family and inhibit the alter-
native complement pathway by binding and displacing properdin
and thereby inhibiting the formation of C3 convertase (Tyson
et al., 2007; Valenzuela et al., 2000). Also, forB. burgdorferi sensu
lato, the complement cascade is an important obstacle to over-
come in order to establish an infection in the mammalian host.
B. burgdorferi sensu lato isolates differ in their susceptibility to
complement-dependent killing (vanDamet al., 1997) by express-
ing proteins on their outer membrane, named Erps and CRASPs,
also known asCsps, which can bind host complement regulators
such as factor H (FH) and factor H-like proteins (FHL-1) (Brissette
et al., 2008) and by expressing a CD59-like protein on their outer
membrane (Pausa et al., 2003). Interestingly, we have previously
shown that inhibition of the complement system by tick salivary
proteins might be instrumental for survival of B. burgdorferi
sensu lato strains that do not have the ability to evade comple-
ment-dependent killing by themselves (Schuijt et al., 2008).
By probing an I. scapularis salivary gland yeast surface display
library with tick-immune rabbit sera, we have identified an
I. scapularis salivary protein with a predicted molecular weight
of 8 kDa, designated P8, and demonstrated that this protein
hasanticomplement activity (Schuijt et al., 2011b).Wehere report
the molecular mechanism by which P8—from here on referred
to as tick salivary lectin pathway inhibitor (TSLPI)—inhibits the
human lectin complement pathway and reveals a crucial role of
the lectin pathway in the host immune response against Borrelia.
RESULTS
Characterization of the I. scapularis Salivary
Protein TSLPI
Recently, we identified an I. scapularis salivary protein—previ-
ously designated P8 (GenBank: AEE89466.1) according to its
molecular weight, but from here on referred to as TSLPI basedCell Hoson its function—by probing a yeast surface display library with
tick-immune rabbit sera (Schuijt et al., 2011b). I. scapularis TSLPI
has several homologs in I. ricinus (GenBank: AAS68352.1 and
GenBank: AAP93884.1), indicating that this protein is conserved
between these closely related Ixodes species, which both
transmit Borrelia. Nucleotide homology between the genes
was 83%–86%, and amino acid similarity between the proteins
was 84%, with 73%–75% identity (Figure 1A). Although TSLPI
is a member of a previously described group of anticoagulant
proteins (Narasimhan et al., 2002), it did not show anticoagulant
activity (Schuijt et al., 2011b). Drosophila-expressed recombi-
nant TSLPI was glycosylated, and removing N-glycans from
the protein backbone using N-glycosidase (PGNase) F reduced
the molecular weight by 4 kDa (Figure 1B). Since TSLPI was anti-
genic in tick-immune rabbits, it is likely a secreted salivary
protein (Schuijt et al., 2011b). Indeed, a signal peptide cleavage
site was predicted, using the web-based software SignalP,
between positions 21 and 22 (Figure 1A), and native TSLPI was
present in I. scapularis saliva when probedwith rTSLPI antiserum
(Figure 1C). In line with this, Ribeiro et al. identified and anno-
tated several proteins with high amino acid sequence identity
to TSLPI (91%–99%) as secreted salivary proteins (Ribeiro
et al., 2006). In Borrelia-free nymphs, TSLPImRNA was upregu-
lated during the course of the tick blood meal (Figure 1D). In the
early phases of nymphal engorgement, B. burgdorferi infection
of ticks resulted in significantly higher TSLPI mRNA levels,
whereas after blood feeding, lower TSLPI mRNA levels were
found in Borrelia-infected ticks compared to Borrelia-free ticks
(Figure 1D). TSLPI mRNA was not detected in midguts of either
Borrelia-free or Borrelia-infected nymphs at all tested time
points of feeding (data not shown), indicating that TSLPI is
preferentially expressed in I. scapularis salivary glands.
TSLPI Impairs Direct Killing ofB. burgdorferi Sensu Lato
Isolates by the Complement System
We have previously shown that rTSLPI protects serum-sensitive
B. garinii A87S against complement-mediated killing (Schuijt
et al., 2011b). We here demonstrate that B. garinii A87S ist & Microbe 10, 136–146, August 18, 2011 ª2011 Elsevier Inc. 137
Figure 2. Recombinant Protein TSLPI Inhibits Complement-Mediated Killing of Borrelia in a Dose-Dependent Manner and Inhibits In Vitro
Chemotaxis and Phagocytosis of Borrelia by PMNs
(A) B. garinii strain A87S was incubated with 12.5% NHS (left), and B. burgdorferi strain N40 was incubated with 12.5% IHS (right) in the presence of increasing
concentrations of BSA (control), control tick salivary protein rP19, or rTSLPI. As a control, spirochetes were also incubated with heat-inactivated (HI) NHS or IHS.
(B and C) rTSLPI (B) or nymphal SGE (C) was preincubated with heat-inactivated OVA-rabbit antiserum (a-OVA) or rTSLPI-rabbit antiserum (a-rTSLPI). After 1.5 hr
of incubation with serum, the percentages of immotile spirochetes were determined. Asterisks indicate a statistically significant difference with the BSA control
(*p < 0.04, **p < 0.004, and ***p < 0.0004).
(D) C5b-9 deposition (red) on B. garinii A87S (green) incubated with 12.5% NHS in the presence of 0.25 mg/ml BSA or rTSLPI for 15 min (upper) and for 30 min
(lower). Right: Percentage of spirochetes with C5b-9 complexes. Results based on triplicate countings of three independent experiments.
(E and F) Phagocytosis of CFSE-labeled viable B. garinii A87S (E) or B. burgdorferi N40 (F) by human PMNs in the presence of 1% or 2.5% NHS or 5% IHS
preincubatedwith 0.25 mg/ml BSA or rTSLPI at 37C. Cells were subjected to FACS analysis after 2, 5, 10, and 30min of incubation. Heat-inactivated IHS andNHS
were used as controls. Asterisks indicate a statistically significant difference with the BSA control (*p < 0.04, **p < 0.004, and ***p < 0.0008).
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dose-dependent manner, utilizing a B. garinii killing assay
with 12.5% normal human serum (NHS) (Figure 2A, left panel).
A growth inhibition assay confirmed the results of actual killing
and the protective effect of rTSLPI against complement-medi-
ated killing of Borrelia (Figure S1A). B. burgdorferi N40, which
is resistant to NHS, was killed by the complement system in
the presence of Borrelia-opsonizing antibodies using 12.5%
Borrelia-immune human serum (IHS), (Figure 2A, right panel).
Strikingly, recombinant TSLPI also protected B. burgdorferi
N40 against antibody-mediated complement-dependent killing
in a dose-dependent manner (Figure 2A, right panel). Heat-
inactivated rTSLPI-rabbit antiserum completely abrogated the
anticomplement activity of rTSLPI (Figure 2B), demonstrating
the neutralizing capacity of these antibodies. In addition,
heat-inactivated rTSLPI-rabbit antiserum substantially reduced
the complement inhibitory activity of I. scapularis salivary gland
extracts (SGEs) (Figure 2C), showing that TSLPI is a dominant
complement inhibitor in tick saliva. To confirm that spirochetal
killing by the complement system was induced by the forma-
tion of MAC complexes, deposition of C5b-9 was examined
on the spirochete outer membrane. The amount of MAC
complexes on the outer membrane of B. garinii A87S was
greatly reduced when incubated with 12.5% NHS for up to
30 min in the presence of 0.25 mg/ml rTSLPI (Figure 2D). Scan-
ning electron microscopy demonstrated that the complement
inhibitory effect of rTSLPI resulted in less bleb formation on
the outer surface of Borrelia spirochetes (Figures S1B
and S1C).
TSLPI Inhibits Phagocytosis of B. burgdorferi
Sensu Lato Strains by Human Neutrophils and
Borrelia-Induced Complement-Mediated Chemotaxis
Activation of the complement system is important for recruit-
ment of immune cells and phagocytosis (Ricklin et al., 2010).
We therefore assessed whether rTSLPI impaired phagocytosis
of Borrelia burgdorferi sensu lato isolates by human neutrophils.
Flow cytometry showed that neutrophils were hampered in
their ability to phagocytize B. garinii A87S in the presence of
0.25 mg/ml rTSLPI and either 1% or 2.5% NHS (Figure 2E).
Human neutrophils also poorly phagocytized B. burgdorferi
N40 in the presence of 0.25 mg/ml rTSLPI and 5% IHS
(Figure 2F).
Complement split products C5a and C3a, generated by the
action of serine proteases, are potent chemoattractants for
leukocytes (Fernandez et al., 1978). Hence, next, the chemoat-
tractant capacity of NHS preincubated with B. garinii A87S in
the presence or absence of 0.5 mg/ml rTSLPI was assessed in a
Transwell in vitro migration assay with human PMNs (Figure 2G).
As shown in Figure 2G, fewer PMNs migrated toward NHS incu-
bated with Borrelia and rTSLPI. Collectively, these data show
that rTSLPI inhibits complement activation on Borrelia, resulting
in impaired in vitro phagocytosis of Borrelia and impaired
Borrelia-induced complement-mediated chemotaxis.(G) The chemoattractant capacity of NHS preincubated with 0.5 mg/ml BSA (contr
migration assay with human isolated PMNs. Fluorescence (fluorescent units, F
represents the number of PMNs migrated in time. Values represent the mean ± S
Cell HosTSLPI Directly Inhibits Activation of the MBL
Complement Pathway
To understand how rTSLPI protected Borrelia against comple-
ment activation, we next assessed whether complement inhibi-
tion by rTSLPI was Borrelia dependent or independent. We
demonstrated that recombinant TSLPI did not bind Borrelia, as
shown by a pull-down assay, suggesting that rTSLPI has a direct
effect on the complement system (Figure 3A). Moreover, when
rTSLPI was preincubated with 12.5% NHS for 30 min, rather
than added simultaneously with the spirochetes, B. garinii A87S
was significantly more protected against complement-mediated
killing (Figure 3B). A similar effect was observed when 12.5%
IHS was preincubated with rTSLPI before it was added to
B. burgdorferi (Figure 3B). To further elucidate the mechanism
by which rTSLPI inhibited complement activation, we investi-
gated the effect of rTSLPI on the classical, alternative, and lectin
pathways. Thus far, the classical and alternative complement
pathways have been shown to be important in Borrelia eradi-
cation by the host. Surprisingly, recombinant TSLPI did not in-
hibit lysis of antibody-sensitized sheep erythrocytes in a CH50
hemolytic assay, demonstrating that the classical complement
pathway was not affected by rTSLPI (Figure 3C). Furthermore,
the alternative pathway (AP50) was not inhibited by rTSLPI (Fig-
ure 3D). Since rTSLPI clearly inhibited complement-mediated
killing of Borrelia, the above negative results prompted us to
investigate the effect of rTSLPI on the MBL complement
pathway. Preincubation of serum with rTSLPI resulted in a pro-
nounced dose-dependent inhibition of C4 deposition using
mannan as a ligand, evidently showing that theMBLcomplement
pathway was inhibited by rTSLPI (Figure 3E).
The Molecular Mechanism by which TSLPI Inhibits
the MBL Complement Pathway
We next set out to define the molecular mechanism by which
rTSLPI inhibited the MBL complement pathway and assessed
whether rTSLPI prevented binding of MBL to its ligands or in-
hibited complement activation through MASP-2 complement
activation. Reduced MBL-ligand binding was observed when
serum was preincubated with rTSLPI (Figure 4A, left panel),
and increasing concentrations of rTSLPI dose-dependently
decreased MBL binding to mannan (Figure 4A, right panel).
In line with these observations, MBL clearly bound to rTSLPI-
coated plates (Figure 4B, left panel), which did not result in acti-
vation of the MBL pathway (Figure 4B, right panel). Posttransla-
tional modifications, i.e., N-linked glycosylation, of recombinant
Drosophila-expressed TSLPI were shown to be crucial for its
effect, since deglycosylation of rTSLPI by PGNase F largely
abrogated the complement inhibitory effect of rTSLPI (Figure 4C),
suggesting that TSLPI binds the carbohydrate recognition
domains (CRDs) of MBL through its N-glycans. To rule out the
possibility that rTSLPI could also impair MASP-2 activity, we
investigated the effect of TSLPI on C4 deposition in a MBL/
MASP complex activity assay. rTSLPI was incubated with bound
MBL/MASP-2 complexes to determine the ability of activatedol) or rTSLPI and 2.5 3 107 B. garinii A87S was assessed in a Transwell in vitro
U) measured at 1 min intervals at the bottom side of the well is shown and
EM. See also Figure S1.
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Figure 3. Direct Effect of rTSLPI on the Complement System by Inhibiting the Lectin Pathway
(A) Binding of B. burgdorferi N40 to rTSLPI as analyzed by western blot as mentioned in text. Salp15 was used as a positive control.
(B) Serumwas preincubated (pre) with BSA, rP19, or rTSLPI for 30min at 33Cor addedwithout preincubation (direct) toBorrelia. Experiments withB. gariniiwere
performed with 12.5% NHS and B. burgdorferi N40 with 12.5% IHS. Asterisks indicate a statistically significant difference (**p < 0.01 and ***p < 0.0001).
(C and D) The effect of rTSLPI on classical (C) and alternative (D) complement pathway-mediated hemolysis was performed by a CH50 and AP50 assay,
respectively. Neutralizing C3 and C1q antibodies were used as controls.
(E) The C4-cleaving activity of the MBL lectin pathway was measured in an ELISA format using mannan-coated microtiter plates in the presence of BSA, anti-MBL
antibody, or several concentrationsof rTSLPI (0.03–0.5mg/ml).Results are representativeof at least two independentassays.Results representmean±SEMof values.
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MBL/MASP2 complexes (Figure S2) bound to mannan-coated
plates, equal amounts of C4 deposition were measured after
incubation with NHS in the presence of rTSLPI or controls (Fig-
ure 4D), demonstrating that rTSLPI does not inhibit MASP-2
activity. Heat-inactivated rTSLPI-rabbit antiserum reduced the
lectin pathway inhibitory activity of I. scapularisSGEs (Figure 4E),
showing that native TSLPI is a major inhibitor of complement
activation through the lectin pathway.
Since the MBL-lectin pathway was specifically inhibited by
rTSLPI, the effect of rTSLPI on complement-dependent killing
was determined in MBL-deficient serum (<0.02 mg/ml MBL).
Unexpectedly, rTSLPI significantly reducedcomplement-depen-
dent killing of B. garinii A87S in MBL-deficient serum (54.7% ±
0.88% in the BSA control group to 31 ± 2.3% in the rTSLPI-
treated group; p = 0.0007) (Figure 5A, right panel). In addition,
when MBL activity was abrogated in NHS (MBL+/+) using
a neutralizing MBL antibody, the percentage of nonmotile spiro-
chetesdecreased from81%±2.3% in thecontrol group to34%±
1.8% in the MBL antibody-treated group (p < 0.0001) (Figure 5A,
left panel). Interestingly, when the MBL antibody was combined
with 0.25 mg/ml rTSLPI, spirochetal killing (20% ± 0.88%) was
significantly reduced compared to MBL antibody alone (p =
0.002) (Figure 5A, left panel). These data suggest that rTSLPI
inhibits additional factors besides MBL in the lectin pathway. It
has been well established that FCNs are also able to initiate the
lectin pathway similarly to MBL. Therefore, we next assessed
whether rTSLPI also influenced FCN-induced C4 deposition.
Faro et al. previously described an assay to specifically measure
L-FCN binding and lectin pathway activation using acetylated
low-density lipoprotein (Ac-LDL) as a ligand (Faro et al., 2008).140 Cell Host & Microbe 10, 136–146, August 18, 2011 ª2011 ElseviIndeed, rTSLPI dose-dependently impaired L-FCN binding to
Ac-LDL and thereby inhibited complement activation (Figure 5B).
RNAi Silencing of TSLPI andTSLPI Immunization Impairs
Borrelia Survival
Having established that TSLPI impaired the lectin pathway of
complement activation and thereby impaired clearance of
Borrelia in vitro, we set out to identify the role of TSLPI in vivo.
We first demonstrated that rTSLPI also protected Borrelia
against complement-dependent killing by normal mouse serum
from C3H mice (Figure 6A). To assess the role of TSLPI in the
transmission of B. burgdorferi from the tick to the host, we
injected B. burgdorferi-infected nymphs with dsRNA directed
against TSLPI (or mock injection as a control). Silencing resulted
in a 13-fold reduction of TSLPImRNA (Figure 6B). The Borrelia
loads in nymphs (Figure 6C) 72 hr postfeeding were significantly
reduced in TSLPI-silenced Borrelia-infected nymphs, showing
the importance of TSLPI for Borrelia persistence in the tick
midguts during feeding. Moreover, transmission of Borrelia
was impaired from TSLPI-silenced nymphs to mice, reflected
by a significantly lower spirochete burden in skin after 7 days
of infection, and in hearts and joints after 21 days of infection
(Figure 6D). To further study the role of TSLPI in Borrelia
transmission, mice were passively administered rTSLPI-rabbit
antiserum. The Borrelia load in skin from rTSLPI-immunized
mice 7 days postinfection was significantly lower and showed
a trend toward lower Borrelia numbers in hearts and joints
21 days postinfection (Figure 6E).
A strong innate immune response at the tick bite site, initiated
by the host complement system, could also impair successful
acquisition of Borrelia by I. scapularis from Borrelia-infecteder Inc.
Figure 4. Mechanism of the Inhibiting Effect of rTSLPI on the MBL Pathway
(A) Serum MBL binding to mannan coated plates was measured in the presence of rTSLPI. Left: serum was preincubated with, 0.25 mg/ml rTSLPI or BSA or
a neutralizing MBL antibody and MBL-deficient serum as a control. Right: MBL binding to mannan coated plates after preincubation of 1:50 NHS with several
concentrations of BSA or rTSLPI.
(B) Serum MBL binding to rTSLPI or rP19 (control) coated plates (left), and complement activation was detected (right).
(C) C4 cleaving activity of the MBL lectin pathway in the presence of PGNase F-treated and untreated 0.25 mg/ml BSA or rTSLPI was determined using 1:40 NHS.
(D) The effect of rTSLPI on MASP-2 activity was determined by capturing MBL/MASP-2 complexes on mannan-coated plates by incubation of 1:50, 1:100, and
1:300 diluted serum in MBL-binding buffer. C4 deposition was measured in the presence of 0.25 mg/ml BSA, rTSLPI, or C1 inhibitor.
(E) Nymphal SGE was preincubated with heat-inactivated OVA-rabbit antiserum or rTSLPI-rabbit antiserum and was subjected to 1:40 NHS, and complement
activation was measured on mannan-coated plates. Data are representative of two independent assays. Results are means ± SEM. See also Figure S2.
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acquisition. The acquisition ofBorrelia by larval I. scapularis ticks
was impaired from rTSLPI-immunized, B. burgdorferi-infected
mice (Figure 6F). In line with this observation, larvae that molted
to nymphs after feeding on rTSLPI-immunized, Borrelia-infected
mice had lower spirochetal loads (Figure 6G).
Together, these data show that TSLPI plays a significant role
in both transmission of Borrelia from the arthropod vector to
the naive mammalian host and acquisition of Borrelia from the
infected mammalian host by larval ticks.
DISCUSSION
We show here that the lectin complement pathway is of para-
mount importance in the eradication of the causative agent of
Lyme disease. Furthermore, we demonstrate how Borrelia
co-opts a tick protein to inhibit the host complement system toCell Hosfacilitate early mammalian infection as well as vector coloniza-
tion. Our findings add to the understanding of the molecular
mechanisms exploited by B. burgdorferi s.l. to survive in its
enzootic life cycle encompassing the mammalian host and the
arthropod vector.
Until now, it has been shown that both the classical and alter-
native complement pathways are involved in complement-
dependent killing of Borrelia (Kurtenbach et al., 2002; van Dam
et al., 1997). Interestingly, rTSLPI impaired complement-depen-
dent killing of B. burgdorferi s.l. through specific inhibition of the
lectin pathway, both in the absence and presence of specific
antibodies, revealing a major role for the lectin pathway in erad-
ication of Borrelia. MBL, the major player in the lectin comple-
ment pathway, is a C-type lectin that forms a noncovalent
complex with MASPs and mainly circulates as a serum protein
(Ip et al., 2009). Via its CRDs, MBL recognizes and binds
polysaccharide structures on various pathogens, resulting int & Microbe 10, 136–146, August 18, 2011 ª2011 Elsevier Inc. 141
Figure 5. L-Ficolin Activity Is Inhibited by rTSLPI
(A) Serum-sensitiveB. garinii strain A87Swas incubatedwith 12.5%normal humanMBL-positive (1.16 mg/ml, left) orMBL-deficient (0.01 mg/ml, right) serum in the
presence of BSA (control), 0.25 mg/ml rTSLPI, or 15 mg/ml neutralizingMBL antibody (anti-MBL), single or combined. As a control, spirochetes were also incubated
with heat-inactivated (HI) NHS. Data represent mean ± SEM of values. Asterisks indicate a statistically significant difference with the control (***p < 0.0001).
(B) Acetylated LDL-coated plates were incubated with serum preincubated with 0.25 mg/ml rP19 or several concentrations of rTSLPI (0.03–0.5 mg/ml). Results are
representative of two independent assays. See also Figure S3.
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which subsequently initiates complement activation by cleavage
of C4 and C2 (Ip et al., 2009). We showed that rTSLPI did not
affect MASP-2 activity, but prevented MBL binding to its ligand.
Removing N-glycans from the protein backbone using PGNase F
largely impaired the complement inhibitory effect of rTSLPI, sug-
gesting that the glycosylated rTSLPI binds to the CRDs of MBL,
blocking downstream activation of the lectin pathway. Although
activation of the lectin pathway is not antibody dependent,
rTSLPI protected serum-resistant B. burgdorferi N40 when
incubated with IHS. Anti-Borrelia antibodies play a crucial role
in effective MAC formation in complement-resistant strains by
altering the outer membrane of Borrelia (Kochi et al., 1991),
which could explain the protective effect of rTSLPI in the
presence of Borrelia antibodies. The importance of the MBL
complement pathway in the direct lysis of Borrelia was under-
scored by the observation that a neutralizing MBL antibody
greatly abrogated immobilization of B. garinii by MBL-sufficient
human serum. Approximately 25% of the general population
is MBL deficient, defined as a MBL serum level <0.5 mg/ml
(Eisen et al., 2008), which could, based on our observations,
make these individuals more susceptible for Lyme disease. Until
now, MBL deficiency has been linked to several infectious
diseases, such as malaria, HIV, and meningococcal and
pneumococcal disease, among others (Ram et al., 2010).
Complement-dependent killing of Borrelia in both NHS- and
MBL-deficient serum was completely abrogated by C1 esterase
inhibitor (Figure S3), a serpin that inhibits both the classical
pathway and lectin pathway of complement activation (Ricklin
et al., 2010; Wouters et al., 2008), indicating that both the clas-
sical and lectin pathway are crucially important in initiating
complement activation on Borrelia. In line with this finding,
Borrelia complement-dependent killing was almost entirely
ablated upon combined inhibition of the classical pathway
and the lectin pathway by both neutralizing C1q antibody and
rTSLPI (Figure S3). Irrespective of whether initiated by the lectin
or classical complement pathway, C3 convertases bound to
the surface of B. burgdorferi s.l. can induce amplification of
the alternative pathway by enhancing C3 activation (Ricklin
et al., 2010; Tyson et al., 2007), which could be detrimental for142 Cell Host & Microbe 10, 136–146, August 18, 2011 ª2011 ElseviBorrelia survival. Recently, a constitutional role for MASP-1 in
activation of the alternative pathway by cleaving factor D was
demonstrated (Takahashi et al., 2010), showing that MASP-1
activation upon MBL and FCN binding results in a direct activa-
tion of the alternative pathway as well. Thus, although the three
complement routes are closely intertwined, our data demon-
strate that the lectin pathway is of crucial importance in the
eradication of Borrelia spirochetes.
Since rTSLPI also significantly reduced killing of Borrelia in
MBL-deficient serum and rTSLPI further reduced complement
killing in normal serum incubated with neutralizing MBL anti-
bodies, we assessed whether rTSLPI inhibited other compo-
nents of the lectin pathway besides MBL. Apart from MBL, three
types of FCNs have been described to activate the lectin
pathway of complement activation, also through the associated
protease MASP-2 (Matsushita, 2009). M-FCN (also known as
FCN-1), L-FCN (also known as FCN-2), and H-FCN (also known
as FCN-3) are identified in humans, and our study shows that
rTSLPI also dose-dependently impairs L-FCN activity.
In addition to direct lysis of B. burgdorferi s.l. cells after MAC
complex formation, complement activation also results in opso-
nization of invading microorganisms and thereby enhancing
phagocytosis by host immune cells (Fernandez et al., 1978;
Ricklin et al., 2010). Indeed, opsonization by complement factors
was essential for phagocytosis of both B. garinii A87S and
B. burgdorferi N40 by human PMNs, since these cells did not
phagocytize Borrelia in the absence of a functional complement
system, even in the presence of Borrelia-specific antibodies.
Importantly, we observed that human PMNs were significantly
impaired in their capacity to phagocytize B. garinii A87S and
B. burgdorferi N40 (data not shown) when NHS was preincu-
bated with rTSLPI. Selected Borrelia strains are able to partially
evade complement activation through the alternative pathway
by interacting with host complement regulator proteins, such
as FH and FHL-1, through expression of Erps and CRASP
proteins on their outer membrane (Brissette et al., 2008) and
by expressing a CD59-like protein that inhibits the assembly of
(sub)lytic complexes (Pausa et al., 2003). However, others
have shown that there was no difference in C3 deposition
between serum-sensitive strains and serum-resistant strainser Inc.
Figure 6. Decreased Borrelia Survival after RNAi Silencing TSLPI and in rTSLPI Antiserum-Immunized Mice
(A) Borrelia was incubated with 12.5% normal mouse serum (NMS) or with heat-inactivated (HI) NMS for 1.5 hr.
(B) TSLPI expression in B. burgdorferi N40-infected nymphs after microinjection of TSLPI dsRNA or mock injection after 72 hr of feeding on mice.
(C) Borrelia flaB levels in nymphs in TSLPI silenced ticks and mock-injected ticks postfeeding on mice.
(D) Borrelia transmission from TSLPI silenced or mock-injected Borrelia-infected nymphs was determined by measuring flaB levels in mouse skin 7 days and in
hearts and joint tissue 21 days postfeeding.
(E) Borrelia loads in murine skin 7 days and hearts or joints 21 days postfeeding on mice passively immunized with rabbit rTSLPI antiserum.
(F) Borrelia flaB levels in pooled larvae after feeding on mice passively immunized with rTSLPI antiserum or control rabbit serum.
(G) A second group of larvae were allowed to molt to the nymphal stage, and Borrelia flaB levels were determined. Horizontal bars represent the mean ± SEM.
Asterisks indicate a statistically significant difference.
Cell Host & Microbe
Lectin Pathway and Borrelia Survivalwhen incubated in human serum (Breitner-Ruddock et al., 1997;
Kochi et al., 1991). Since C3b deposition and its degradation
products iC3b, C3c, and C3d play a major role in complement
receptor-induced phagocytosis (Ricklin et al., 2010), this indi-
cates that although serum-resistant spirochetes evade direct
lysis through the alternative complement route, they are equally
susceptible to phagocytosis compared to serum-sensitiveCell HosBorrelia. In contrast, inhibition of complement-initiating mecha-
nisms on Borrelia, such as inhibition of the lectin pathway by
TSLPI, is likely to result in decreased C3 opsonization. This could
explain the observed impaired phagocytosis of Borrelia by
neutrophils incubated with NHS in the presence of rTSLPI.
Interestingly, apart from initiating complement activation, MBL
and FCNs also act as opsonins in the absence of C3 throught & Microbe 10, 136–146, August 18, 2011 ª2011 Elsevier Inc. 143
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addition, MBL has been shown to cooperate with TLR-2/TLR-6
to enhance phagosome signaling in response to bacteria (Ip
et al., 2008), further underscoring the relevance of inhibition
of the lectin pathway by TSLPI for B. burgdorferi.
Although rTSLPI inhibited Borrelia-induced MBL complement
pathway-mediated chemotaxis in vitro, preliminary experiments
indicate that rTSLPI did not impair influx of phagocytes in mice
intradermally injected with 104 B. garinii strain A87S (data not
shown). It is possible that other tick proteins are necessary to
impair innate immune responses toward Borrelia. Indeed, during
tick feeding other salivary proteins are able to inhibit additional
parts of the innate immune system such as dendritic cells,
neutralizing chemokines, and inflammatory cytokines, among
other reported anti-inflammatory proteins (Hovius et al., 2008),
which could also play a role in protecting Borrelia from clearance
by the host immune system.
TSLPI was differentially expressed during the course of tick
feeding. Interestingly,TSLPIwasupregulated inBorrelia-infected
ticksduring the early stagesof tick feeding. Furthermore, the anti-
complement effect of native TSLPI in tick SGE was inhibited in
both the Borrelia killing assay and lectin pathway assay in the
presence of anti-rTSLPI antiserum, indicating that TSLPI is a
major inhibitor of complement activation though the lectin
pathway onBorrelia in Ixodes tick saliva and underscoring its bio-
logic significance. Indeed, after silencing TSLPI in ticks, we
showed that Borrelia transmission to mice was significantly
impaired after 72 hr of tick feeding. Moreover, Borrelia loads in
ticks after feeding were also more than 2-fold reduced. Others
have shown that complement is still active in midguts of Ixodes
ticks postengorgement (Papatheodorou and Brossard, 1987).
Thus, our data suggest thatBorrelia is protected against comple-
ment activation by TSLPI in midguts of ticks. We next extended
our studies by passively transferring rTSLPI-rabbit antiserum to
mice. After 72 hr of feeding on rTSLPI-immunized mice, spiro-
chete transmission from Borrelia-infected ticks to mice was
significantly reduced as well. Since immunization against rTSLPI
did not result in total abrogation ofBorrelia transmission from the
tick to the host, a future tick antigen-based vaccine to prevent
Lyme borreliosis should probably be based on a combination of
tick proteins expressed during the course of tick feeding and
important for Borrelia transmission (Schuijt et al., 2011a).
Together, our findings implicate that TSLPI is crucially important
for Borrelia survival both in the tick vector and in the host during
early infection. While TSLPI directly and specifically inhibited
the lectin pathway of complement activation, this could facilitate
transmission of other pathogens as well. Although TSLPI is
specifically upregulated in tick salivary glands upon infection
with B. burgdorferi, and not Anaplasma phagocytophilum,
preliminary data show impaired A. phagocytophilum transmis-
sion by nymphs to rTSLPI-immune mice, using a mouse model
for A. phagocytophilum infection (data not shown).
We also assessed the role of TSLPI in survival andmigration of
Borrelia from the mammalian host to ticks, a process referred to
as acquisition. These experiments were performed with larval
I. scapularis ticks, since larvae naturally acquire B. burgdorferi
s.l., and we have previously shown that TSLPI is expressed in
engorging larvae (Schuijt et al., 2011b). Borrelia acquisition
from Borrelia-infected mice by larval ticks was impaired when144 Cell Host & Microbe 10, 136–146, August 18, 2011 ª2011 Elsevimice were immunized with rTSLPI, indicating that TSLPI activity
is crucial at the tick bite site for Borrelia in order to survive and
migrate into the tick midgut as well. Thus, TSLPI is a tick salivary
protein that plays a significant role in both Borrelia transmission
to the mammalian host as well as Borrelia acquisition and
persistence in ticks.
In conclusion, we have shown a crucial role for the lectin
complement pathway in the eradication of the causative
agent of Lyme disease. Furthermore, we have identified and
characterized a TSLPI that abates complement activation on
B. burgdorferi s.l. by impairing activation of the lectin comple-
ment pathway, which leads to impaired clearance of Borrelia.
TSLPI silencing in ticks and TSLPI immunization studies demon-
strated diminished Borrelia transmission and acquisition by
ticks in which TSLPI activity was impaired, implying a crucial
role for TSLPI in the enzootic life cycle of B. burgdorferi and
revealing the potential of TSLPI as a component in a multivalent
tick protein-based vaccine to prevent Lyme disease.
EXPERIMENTAL PROCEDURES
Ticks and Animals
I. scapularis nymphs and larvae were obtained from a tick colony at the
Connecticut Agricultural Experiment Station in New Haven, CT. Ticks were
maintained at 23C and 85% relative humidity under a 14 hr light/10 hr dark
photoperiod. Borrelia-infected nymphs were generated by placing larvae on
B. burgdorferi-infected C3H mice, and fed larvae were molted to nymphs.
For active immunization studies, 6-week-old inbred NewZealandwhite rabbits
(Charles River Laboratories) were obtained and immunized as described
before (Schuijt et al., 2011b). Preparation of I. scapularis nymphal SGEs and
adult saliva are described in Supplemental Experimental Procedures. For
the passive immunization experiments, 4- to 6-week-old female C3H/HeJ
mice (Jackson Laboratory) were used. The protocol for the use of mice and
rabbits was reviewed and approved by the Yale Animal Care and Use
Committee. The Animal Care and Use Committee of the University of Amster-
dam approved all animal experiments performed in Amsterdam, and experi-
ments have been conducted according to national guidelines.
Recombinant Salivary Proteins
Cloning and expression of TSLPI and p19 in theDrosophila Expression System
(Invitrogen) and purification of recombinant protein were performed as
described before (Schuijt et al., 2011b). See the Supplemental Experimental
Procedures for more details. Deglycosylation of recombinant TSLPI with
PNGaseF (Sigma)wasperformedaccording to themanufacturer’s instructions.
Tick RNA Isolation and Quantitative RT-PCR
Ticks were allowed to feed for 24 hr, for 72 hr, or to repletion (between 80 and
96 hr after initiation of tick feeding, ticks were monitored two times a day and
recovered after detachment from the hosts) on experimental and control
animals. Nymphs were dissected, salivary glands and midguts were pooled
(three ticks) and homogenized, and RNA was extracted using the RNeasy
Mini Kit (QIAGEN). DNA was removed by on-column DNase digestion. The
same procedure was performed with unfed ticks. Total RNA was quantified
(5–6 ng of total RNA), and the quality of the RNA was assessed (Nanodrop
2000c). cDNA was synthesized using the iScript RT-PCR kit (Bio-Rad).
According to the manufacturer’s instructions, 2 ml of cDNA synthesis reaction
was analyzed by quantitative PCR for the expression of tick actin and TSLPI
using the iQ SYBR Green Supermix (Bio-Rad) on a MJ cycler (MJ Research)
and previously described primers (Schuijt et al., 2011b).
Assay for Detection of Complement-Mediated Killing
of Borrelia Spirochetes
The serum-sensitive Borrelia garinii isolate A87S was used (107 spirochetes
ml1) to determine complement-mediated killing in NHS (NHS) as described
earlier (Schuijt et al., 2008). The serum-resistant Borrelia burgdorferier Inc.
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complement-mediated killing in Borrelia IHS (IHS). See Supplemental Experi-
mental Procedures for more details.
Deposition of Terminal C5b-9 Complement Complexes
For detection of the terminal C5b-9 complement complexes on the borrelial
surface, a previously described C5b-9 immunofluorescence assay was used
(Schuijt et al., 2008). See Supplemental Experimental Procedures for more
details.
Phagocytosis Assay
Borrelia phagocytosis assaywas performed as described before (Hovius et al.,
2009). Experiments with human PMNs were performed with minor modifica-
tions described in Supplemental Experimental Procedures.
Neutrophil Migration Assay
Human PMNs were isolated from blood with Polymorphprep (Axis-Shield)
according to the manufacturer’s instructions. PMN migration was assessed
as previously described (Hovius et al., 2009). See Supplemental Experimental
Procedures for more details. 12.5%NHSwas preincubated with 0.5 mg/ml BSA
or rTSLPI for 30 min. Subsequently, 2.5 3 107 B. garinii A87S was added and
incubated for 30 min at 37C. Spirochetes were pelleted (30 min, 20,0003 g)
and the supernatant was checked for the absence of Borrelia using dark-field
microscopy. Supernatant was used to dilute the NHS to a final concentration
of 2.5% and was added to the bottom wells, after which cell migration was
assessed.
Borrelia Binding Assay
B.burgdorferiN40 (2.53107)was incubatedwith0.1 ng/ml recombinantSalp15
or TSLPI in PBS/0.1% BSA for 1 hr at room temperature. Borreliawas pelleted
and the pellet and supernatant were separated. The pellet was washed two
times in 1.5 ml PBS/0.1% BSA and was resuspended in the same volume as
the supernatant. Equal volumes of supernatant and pellet were used to run
on a SDS gel and transferred to nitrocellulose membranes. The membranes
were blockedwith PBS/5%milk, and immunoblotswere probed and visualized
with anHRP-conjugated anti-V5 antibody (Invitrogen) and the enhanced chem-
iluminescence Western Blotting Detection System (GE Healthcare, NJ).
Classical and Alternative Complement Pathway Assays
Complement hemolytic activity of the classical pathway (CH50) was deter-
mined by using antibody-coated sheep red blood cells (SRBCs). Opsonized
SRCBs were incubated for 1 hr with several dilutions of NHS preincubated
with either 0.25 mg/ml neutralizing C3 antibody (anti-C3-2, Sanquin), 50 mg/ml
neutralizing C1q antibody (anti-C1q-85, Sanquin), 0.25 mg/ml BSA, or
0.25 mg/ml rTSLPI in GVBS (VBS with 5.8% [w/v] sucrose, 0.5% [w/v] human
serum albumin, 10 mM CaCl2, and 2 mM MgCl2 [pH 7.4]) in a shaker at
37C. Complement hemolytic activity of the alternative pathway (AP50) was
performed by using rabbit red blood cells (RRBCs). RRBCs were incubated
for 1 hr in a shaker at 37C with several dilutions of serum preincubated with
0.25 mg/ml neutralizing C3 antibody, BSA, or rTSLPI in GVBS containing
10 mM MgEGTA. For positive control of the CH50 and AP50, red blood cells
were incubated in distilled water (100% lysis of cells), and for the negative
control the red blood cells were incubated in GVBS or GVBS with 10 mM
EDTA (0% lysis of cells). Plates were centrifuged at 10003 g for 5 min, and
hemolysis was determined by measuring OD at 414 nm using the iMark
Microplate Reader (Bio-Rad).
Lectin Pathway of Complement C4 Activation
High binding microtiter plates (Microlon, Greiner) were coated with 10 mg/ml
mannan (Sigma) or acetylated LDL (A-LDL) (Biomedical Technologies Inc.) in
a moist chamber overnight at 4C. A-LDL is a useful ligand to specifically
determine L-FCN activity (Faro et al., 2008). Wells were blocked with blocking
buffer (1:10 dilution of Starting Block [Pierce] in TBS with 0.05% Tween 20) at
room temperature for 1 hr. After washing with TBS/0.05% Tween 20/5 mM
CaCl2, several NHS dilutions preincubated for 30 min with either BSA, rP19,
or rTSLPI were incubated in the wells in C4 activation buffer (4 mM Na-diethyl-
barbiturate, 145 mM NaCl, 2 mM CaCl2, 1 mMMgCl2, 2% [v/v] Starting Block,
0.02% [v/v] Tween 20) for 1 hr at room temperature. Wells were washedCell Hosand incubated with biotinylated monoclonal mouse anti-human C4 IgG
(0.25 mg/ml). After washing, avidin-conjugated HRP in TBS/Tween 20/Ca
was incubated for 30 min at room temperature. Wells were washed, TMB
substrate was added, and the absorbance at 450 nm was measured using
the iMark Microplate Reader (Bio-Rad).
MBL Binding
Wells (Microlon, HB, Greiner) were coated with 10 mg/ml mannan overnight
at 4C, blocked with a 1:10 dilution of Starting Block (Pierce) in TBS with
0.05%Tween 20, andwashed with TBS/Tween 20/Ca. Several serum dilutions
were incubated with BSA or rTSLPI for 30 min in MBL binding buffer (20 mM
Tris-HCL, 1 M NaCl, 10 mM CaCl2, 1 mg/ml BSA, 0.05% [v/v] Triton X-100),
and serum MBL was allowed to bind the mannan-coated wells overnight at
4C. Wells were washed with TBS/Tween 20/Ca and incubated with mono-
clonal mouse anti-human 10 mg/ml MBL antibody (Sanquin) in TBS/Tween
20/Ca for 1 hr at room temperature. After washing, HRP-conjugated anti-
mouse IgG was added and was incubated for 45 min at room temperature.
The amount of MBL bound to the plates was determined by reading the absor-
bance at 450 nm using the iMark Microplate Reader (Bio-Rad).
MBL/MASP-2 Complex Activity Assay
The MBL/MASP-2 complex activity assay was used to determine C4 cleavage
activity of MASP-2 as previously described (Gadjeva et al., 2004). Serum
MBL/MASP-2 complexes were bound to mannan-coated plates as described
above by using several serum dilutions (1:50, 1:100, and 1:300) in MBL binding
buffer overnight at 4C. After washing the plates, MBL-deficient serum was
used as a C4 source in a final dilution of 1:100 and incubated with 0.25 mg/ml
rTSLPI, BSA, or C1 inhibitor (Sanquin) in C4 dilution buffer for 1 hr at room
temperature. C4 activation and deposition on the plates as well as the amount
of MBL bound on the plates after incubation of BSA or rTSLPI was determined
as described above.
Passive Immunization and B. burgdorferi Transmission
In experiments to address Borrelia transmission to mice, six B. burgdorferi
N40-infected nymphs were placed on each mouse passively immunized by
intraperitoneal inoculation with 200 ml serum obtained from rTSLPI or OVA
immunized rabbits. Nymphs were allowed to feed to repletion. Salivary glands
andmidguts were dissected for mRNA purification as described above. Trans-
mission was assessed by quantitative PCR of DNA isolated from skin at 7 days
and hearts and joints at 21 days postengorgement. To address Borrelia
acquisition, at least 30 pathogen-free I. scapularis larvae were placed on
each B. burgdorferi-infected rTSLPI immune mouse and allowed to feed to
repletion. At least three mice were used in each experiment. Larvae were
analyzed in pools of five.
RNAi Silencing of TSLPI in Borrelia-Infected I. scapularis Nymphs
Primers were designed by addition of a T7 promoter site (TAATACGACTCAC
TATAGGGAGA) at the 50 end of the forward (AGGCTGCGACTATTACTGCTG)
and reverse (TTGAATCGGTTGTCAAATGG) primers. dsRNA complementary
to the TSLPI gene was synthesized using the MEGAscript RNAi kit (Ambion).
The dsRNA was purified and quantified spectroscopically. dsRNA (5 nl, 1 3
1012 molecules/ml) was injected into the body of Borrelia-infected nymphs
using 10 ml microdispensers (Drummond Scientific) drawn to fine-point
needles by using a micropipette puller (Sutter Instruments, Novato) or with
the same volume of dsRNA elution buffer (mock), provided by the RNAi kit
(Ambion) alone. The needles were loaded onto a micromanipulator (Narishige,
Tokyo) connected to a Nanojet microinjector (Drummond Scientific). At least
50 nymphs were used in each group. The ticks were allowed to rest for 3 hr
before placement on mice. Ticks were allowed to feed for 72 hr and then
were weighed and dissected for mRNA isolation and quantitative RT-PCR
as described above. Borrelia transmission was assessed by quantitative
PCR of DNA isolated from skin at 7 days and hearts and joints at 21 days
postengorgement.
Statistical Analysis
The significance of the difference between the mean values of the groups was
analyzed using a two-tailed Student’s t test with Prism 5.0 software (GraphPad
Software), and the p value is indicated by asterisks in the figures.t & Microbe 10, 136–146, August 18, 2011 ª2011 Elsevier Inc. 145
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